1. Staying Social after a Cancer Diagnosis

    After a cancer diagnosis, your social life will probably change. Cancer can be isolating. You may not feel up for the activities you once enjoyed. This can either be due to feeling poorly physically or emotionally. Side effects may keep you homebound in the days following treatment. Or, your immune system may be so weak that your healthcare team suggests avoiding crowds. Even when you feel well physically, you may be dealing with depression or anxiety. Cancer is a scary, challenging diagnosis...

    Read More
  2. We Are Turning It Red for Blood Cancer Awareness Month

    Coming to a city near you starting Sept 1st! We are lighting it red for YOU as a symbol of our support and in honor of Blood Cancer Awareness Month. Together, we bring light to the darkness of cancer. Join us by looking for a participating location near you (list below) that’s turning it red for Blood Cancer Awareness Month, SHARE your photo with #FightBloodCancer and you may win a fun prize!

    Read More
  3. LLS Investment Pays Off: FDA Approves Immunotherapy for Blood Cancer Patients

    August 30 commemorated a new era in cancer treatment with the U.S. Food and Drug Administration (FDA) approval of a new, cutting-edge gene therapy that reprograms a patient’s immune system to find and kill cancer cells. This highly personalized therapy known as Kymriah (previously CTL019 or tisagenlecleucel-T) signifies the promise of CAR (chimeric antigen receptor) T-cell immunotherapy, an approach that The Leukemia & Lymphoma Society (LLS) recognized early on held great promise f...

    Read More
  4. Surviving Cancer, Thriving in Life—Transition Back to School Parent Experience Survey

    Dear Parents, LLS is collaborating with researchers at the Kennedy Krieger Institute and Johns Hopkins who are interested in learning more about the experiences and challenges of childhood cancer survivors and their caregivers related to the transition back to school after a diagnosis of cancer. According to our records, you have a school-aged or older child who has been treated for cancer and has returned to a formal school setting. We would appreciate your help by your participation in t...

    Read More
  5. MPN News and Updates From ASCO 2017

    As part of our coverage from the 2017 American Society of Clinical Oncology annual meeting, Dr. Srdan Verstovsek from The University of Texas MD Anderson Cancer Center provides a hopeful update for patients living with MPNs.

    Read More
  6. Neuropathy

    Some chemotherapy drugs have been known to affect the peripheral nerves in the nervous system, which can lead to pain, numbness or burning in your limbs, hands or feet - a condition called Chemo Induced Peripheral Neuropathy. If you’re feeling symptoms of neuropathy, talk to your doctor about what you’re experiencing. It’s a frustrating side effect, but if you’re able to be flexible in your treatment schedule, you may be able to reduce your risk by altering the timing of your treat...

    Read More
  7. LLS Applauds Another Advance for Blood Cancer Patients

    August 3, 2017 (Rye Brook, NY) - The Leukemia & Lymphoma Society (LLS) applauds the U.S. Food and Drug Administration (FDA) approval today of CPX-351 (VyxeosTM), an innovative combination of two chemotherapy drugs being used to treat two high-risk subgroups of acute myeloid leukemia (AML) patients. After more than four decades of little progress in treating AML, this approval marks the third drug approval for AML patients in just the past three months. LLS contributed sustained and sign...

    Read More